We got the RSV immunization for our 3-month-old before monsoon season. Dr. Garima explained everything clearly — what it is, why it matters, and what to expect. Our baby had zero fuss. So relieved to have this protection during the high-risk months.
Nirsevimab – CDSCO Approved
RSV Immunization for Babies in Gurgaon
Protect your little one from respiratory syncytial virus with nirsevimab – single-dose RSV immunization at KinderCure
Next RSV Season Starts August 2026 | Plan Your Baby's Protection Early
5-StarGoogle Rating
9+ YearsExperience
Same DayAppointments
Nirsevimab immunization available — contact us for current pricing. Includes consultation and post-immunization monitoring.
Baby born recently? Consult now to plan RSV protection before monsoon season.
Prior appointment recommended for RSV immunization
RSV Vaccine at a Glance
Nirsevimab (brand name Beyfortus) is a CDSCO-approved single-dose immunization that protects babies from RSV — the leading cause of infant hospitalisations in India. One injection provides 5 months of protection, covering the entire RSV season (August–January). Recommended by the IAP, CDC, and AAP for all babies under 1 year. Available at KinderCure Clinic, Gurgaon — same-day appointments, Monday–Saturday.
RSV Vaccine Availability in India
Everything parents need to know about getting the RSV vaccine for their baby in India.
CDSCO Approval: Nirsevimab was approved by India's drug regulator (CDSCO) in August 2024 for RSV prevention in infants, marketed under the brand name Beyfortus.
IAP Recommendation: The Indian Academy of Pediatrics (IAP) recommends nirsevimab for all infants under 1 year entering their first RSV season, and for high-risk infants up to 24 months.
Where to Get It in Delhi NCR: Nirsevimab (Beyfortus) is available at KinderCure Clinic, Gurgaon — with same-day appointments Monday to Saturday. Stock maintained for immediate administration.
How It Differs from Maternal RSV Vaccine: The maternal RSV vaccine (Abrysvo) is given to pregnant women to pass antibodies before birth — but it is not yet available in India. Nirsevimab, given directly to infants after birth, is currently the only option for RSV protection in India.
Understanding RSV: Why Protection Matters
What is RSV?
RSV is a highly contagious virus that causes respiratory infections. Early signs look like a mild cold—congestion, runny nose, irritability, fever. As infection worsens, it can lead to severe lung illnesses like bronchiolitis or pneumonia.
Why Babies Are Vulnerable
Babies lack strong immune defences. Their immune system is still developing, so they may not have the antibodies needed to fight off their first RSV infection. RSV is the top cause of hospital stays in babies under 1—16 times more hospitalisations than the flu.
RSV in India
RSV is the leading cause of lower respiratory tract infections in Indian infants, contributing to over 1 lakh pediatric hospitalizations annually. Globally, RSV causes approximately 33 million respiratory infections each year. Early protection with nirsevimab is crucial for your baby's health.
Why Nirsevimab?
Nirsevimab is not a vaccine—it gives your baby ready-made preventive antibodies, an extra layer of protection their body needs to fight RSV right away. Recommended by the CDC, AAP, and IAP for all infants entering their first RSV season.
RSV Season in India
AugustJanuary
RSV season in India coincides with the monsoon and winter months, typically from August to January. Peak activity is observed between September and December. This is the critical window when your baby needs protection the most.
Who Should Get RSV Immunization?
All Infants Under 1 Year
All babies under 1 year of age entering their first RSV season are recommended to receive RSV immunization for protection against severe respiratory illness.
High-Risk Infants Up to 24 Months
Premature babies are especially vulnerable to RSV because their lungs are not fully developed at birth, leaving them with fewer natural defences against respiratory infections. Babies born before 37 weeks, those with chronic lung disease (bronchopulmonary dysplasia), congenital heart disease, or weakened immunity are recommended for RSV immunization up to 24 months of age during their second RSV season. If your baby spent time in the NICU, consult with our pediatricians about RSV protection timing.
How Nirsevimab Works
1
Consultation
Our pediatricians assess your baby's health and eligibility for RSV immunization during a brief consultation.
2
Single Injection
Nirsevimab is given as a single intramuscular injection, typically in the thigh. The procedure is quick and gentle.
3
Immediate Protection
Nirsevimab works right away. Unlike vaccines that teach the body to make antibodies, nirsevimab directly gives your baby ready-made antibodies.
5 Months of Protection
A single dose of nirsevimab provides protection for approximately 5 months—enough to cover your baby for an entire RSV season. Preventive antibodies have been safely used in medicine since 1996, and specifically for RSV in babies for over 25 years.
What to Expect
Before the Visit
Book your appointment in advance. Ensure your baby is healthy on the day of the visit. Bring any previous health records or vaccination cards.
During the Visit
The pediatrician will conduct a brief health assessment. The injection takes just a few seconds. We'll monitor your baby for a short period after administration.
After the Visit
Mild side effects like slight redness at the injection site or mild fever may occur but typically resolve quickly. Reach out to our team if you have any concerns.
Why Choose KinderCure for RSV Immunization?
Serving families in Gurgaon, Golf Course Extension Road, Sohna Road, and across Delhi NCR
Respiratory Expertise
Our pediatricians have extensive experience managing respiratory conditions in infants, with backgrounds from Indian Air Force medical services, VMMC Safdarjung Hospital, and leading healthcare organizations.
Nirsevimab In Stock
We stock nirsevimab (Beyfortus brand) at KinderCure. Prior appointment ensures we're prepared for your baby's visit.
Convenient Scheduling
Same-day appointments available. Open Monday-Saturday 10am-9pm and Sunday 12pm-4:30pm for your convenience.
Child-Friendly Environment
Our clinic is designed to make babies and parents comfortable, with gentle care and minimal waiting times.
Parents Trust KinderCure for RSV Immunization
Our twins were born at 32 weeks and the pediatrician at KinderCure recommended Beyfortus before discharge season. The whole process was smooth — one quick injection each, monitored for 20 minutes, and we were done. Both babies sailed through RSV season without any respiratory issues.
I was hesitant about a newer immunization, but Dr. Garima took the time to share the clinical data and IAP recommendations. The fact that it is a single dose covering 5 months made it an easy decision. Highly recommend KinderCure for any parent considering RSV protection.
Frequently Asked Questions About RSV Immunization
Get answers to common questions about RSV protection for your baby
RSV (Respiratory Syncytial Virus) is a highly contagious virus that causes cold-like symptoms in older children and adults but can be severe in infants. Early signs include congestion, runny nose, irritability, decreased appetite, and fever. In babies, RSV can progress to severe lung illnesses like bronchiolitis and pneumonia. RSV is the leading cause of hospitalisations in babies under 1 year—in fact, babies are hospitalised from RSV 16 times more than from the flu. Globally, RSV causes approximately 33 million lower respiratory infections annually.
Nirsevimab is a monoclonal antibody approved by CDSCO (India's drug regulator) in August 2024 for RSV prevention in infants, marketed as Beyfortus in India. It is NOT a vaccine—instead, it provides ready-made preventive antibodies that give your baby an extra layer of protection immediately. A single dose provides approximately 5 months of protection, covering the entire RSV season. Nirsevimab is recommended by the CDC, AAP, and IAP for all infants entering their first RSV season.
In India, RSV season typically runs from August to January, coinciding with the monsoon and winter months. Peak RSV activity is usually observed between September and December. This is the ideal time to ensure your baby is protected with nirsevimab immunization.
According to CDC, AAP, and IAP guidelines, RSV immunization with nirsevimab is recommended for all infants under 1 year of age entering their first RSV season. High-risk infants (premature babies, those with chronic lung disease, congenital heart disease, or weakened immunity) up to 24 months may also benefit from protection during their second RSV season. Consult with our pediatricians to determine if your baby is eligible.
A single dose of nirsevimab provides protection for approximately 5 months, which typically covers the entire RSV season. This is sufficient to protect your baby through the high-risk months from August to January.
Studies showed that nirsevimab was similar in safety to a placebo. Common side effects are mild and may include a rash (red or bumpy skin), pain, swelling, or a hard spot at the injection site. Serious allergic reactions are rare but possible—seek medical help immediately if your child shows facial swelling, difficulty breathing, or bluish skin tone. Our pediatricians will monitor your baby for a short period after administration.
Nirsevimab should not be given to infants with a history of serious allergic reactions to nirsevimab or any ingredient in the formulation. Additionally, inform our pediatricians if your child has bleeding or bruising problems, as an injection could cause issues. If your baby has previously received palivizumab in the same RSV season, they should not receive nirsevimab. Our team will review your baby's medical history to ensure safe administration.
Yes, nirsevimab can be safely administered alongside routine childhood vaccines. According to CDC, AAP, and IAP guidelines, co-administration with vaccines like DTaP, Hepatitis B, IPV, and others does not affect the efficacy or safety of either. This means your baby can receive RSV immunization during a regular vaccination visit.
Yes, premature babies are actually among the highest priority candidates for nirsevimab as they are at increased risk for severe RSV illness. Our pediatricians will assess your premature baby and recommend the appropriate timing for immunization.
Infant RSV immunization (nirsevimab) is given directly to babies after birth and provides immediate protection. The maternal RSV vaccine (Abrysvo) is given to pregnant women to pass antibodies to the baby before birth. Currently, the maternal RSV vaccine is not available in India, making nirsevimab the recommended option for RSV protection. Both approaches should not be used together for the same infant.
If your baby is still within the eligible age range and RSV season is ongoing, they can still receive nirsevimab. Contact KinderCure to discuss the best approach for your baby's situation.
Nirsevimab is given as a single intramuscular injection, typically in the thigh muscle for infants. The procedure is quick and performed by our experienced pediatric team in a comfortable, child-friendly environment.
Preventive antibodies (monoclonal antibodies) have been used as medicine since 1996, and preventive antibodies specifically for RSV infections have been given to babies for over 25 years. Studies showed that nirsevimab was similar in safety to a placebo, with common side effects being mild rash or injection site reactions.
Yes, nirsevimab helps prevent RSV-related bronchiolitis—a common and potentially serious lung infection in babies where the small airways become inflamed. RSV is the leading cause of bronchiolitis in infants. By providing ready-made antibodies against RSV, nirsevimab significantly reduces the risk of severe bronchiolitis and related hospitalisations.
You can book an RSV immunization (nirsevimab) appointment by messaging us on WhatsApp. Prior appointment is recommended as we ensure adequate stock and preparation for your baby's visit. You can also request a callback if you prefer to speak with our team.
Nirsevimab (Beyfortus) is technically not a vaccine — it is a monoclonal antibody that gives your baby ready-made protection against RSV. Unlike vaccines that teach the body to produce antibodies, nirsevimab provides immediate protection from a single dose. It is commonly referred to as "RSV vaccine" and is the recommended form of RSV prevention for infants in India, approved by CDSCO and recommended by the IAP.
Information on this page is based on guidelines from the Centers for Disease Control and Prevention (CDC), American Academy of Pediatrics (AAP), Indian Academy of Pediatrics (IAP), and the official nirsevimab prescribing information. Nirsevimab (marketed as Beyfortus) was approved by CDSCO India in August 2024.
Last updated: February 2026
Ready to Protect Your Baby from RSV ?
RSV season peaks September–December. Book now to ensure your baby is protected before peak season.